Malaria Control Programme in Thailand
1. Background
In 1949 malaria was the leading cause
of death with over 38,000 deaths, a rate of 201.5 per 100,000 population. The only two control measures being
available were drug distribution and mosquito protection.
A WHO-UNICEF Malaria Control
Demonstration Project was conducted in a northern province. During the same period the Thai
Government established similar projects in other areas. The results of these projects showed
that DDT residual spraying was encouraging. In 1951 the government, with US assistance developed country-wide
Malaria Control Programme. By
1955 the control programme was gradually extended to cover 12 million
population. Active case detection
was also started in some areas.
In
1963 malaria death rate showed a reduction to 22.8/100,000 population. The first plan of operation for the Malaria
Eradication Programme commenced, according to WHO policy. Following difficulties of funding and
technical constraints, Malaria Control Programme was developed in
1971-1973 with more attention directed to the forested areas and was considered
as a long term project in the Fifth Five -Year National Socio -economic
development plan.
In
1995 following the adoption of the Global Malaria Control Strategy and the
recommendations of the external and internal review panels, the malaria control
policy was revised.
2. The Current Malaria Control
Programme.
Objectives of Malaria Control Under
the Eighth Five-Year National Health Development Plan (1997-2001)
A General Objectives
1.To reduce malaria morbidity rate
and mortality rate.
2.To minimize duration of illness and
reduce the risk of severity and
complication
3.To
enable communities having capacity for solving malaria problem on the basis of
self-reliance.
B Specific Objectives
1. To reduce malaria incidence in 30 bordering provinces to 3,
or less, per 1,000 population by 2001.
2. To reduce country malaria incidence to 1, or less, per 1,000
population by 2001.
3.
To reduce country malaria mortality rate to 0.4, or less, per 1,000 population
by 2001.
4.
To reduce pre-treatment time-lag (time from onset of illness to treatment) to 7
days or less.
5. To reduce number of severe and complicated malaria
cases by 20 percent by 2001 (as compare with 1996).
6. To reduce morbidity rate of malaria repeating cases
among population at high risk by 20 percent by 2001 (as compare with 1996).
7. To prevent re-establishment of transmission in
non-transmission but high receptive area by reducing morbidity rate to 5, or
less, per 10,000 population in such area.
8. To eliminate malaria transmission in 4 provinces such
as Phayao, Udonthani, Khonkaen and Pattani; and prevent re-establishment of
transmission in 14 malaria eradicated provinces.
3. Programme Priorities and
strategies
Although the Eighth National Health
Development Plan is focusing on human resource development, there are some
major malaria problems remaining at the end of the Seventh National Health
Development Plan. These are
summarized as following:
1. Transmission at the borders among foreign labour force
is still high.
2. Drug resistance along the Thai-Cambodian and Thai-Myanmar
borders causes considerable amount of budget for treatment.
3. Even though indoor residual spraying using DDT still
effective but less acceptable and less desirable due to impact on environment.
4. Health Education among population at risk to obtain less
risky behavior is unsuccessful.
5. Emerging of epidemics due to migration of non-immune labour
force following development projects into high receptive areas.
6. High case-fatality rate among non-immune such as tourists
and migrants.
National
Malaria Control Programme therefore adopts the Global Strategy for Malaria
Control (WHO) and develops strategies as following:
Strategies
1. Disease Management: comprising diagnosis, treatment,
referral system and case follow-up;
1.1 To strengthen prompt treatment
among risk group both residences and
foreigners.
1.2 To develop National Drug Policy aiming
to provide proper and appropriate treatment for all population at risk in order to avoid encouraging drug
resistance situation.
1.3 To develop commensurate collaboration
on malaria treatment between public and concerning private sectors.
2. Disease Prevention:
2.1 To strengthen health education
and public relation among all risk groups aiming at healthy behavior and cooperation
to disease control.
2.2 To promote personal protection using bed-net, impregnated
net and repellent.
2.3 To operate selective vector
control using bio-environmental measure and pyrethroids or other appropriate chemicals
acceptable by communities.
3. To strengthen malaria control
operation along bordering areas emphasizing transmission-prone areas and areas with
excessive labor force of foreigners.
4. Prediction, Prevention and Epidemic Control:
4.1 To develop Information System,
Information Technology and Epidemic Early Warning System which are sensitive to the change of factors leading to epidemic, in order to obtain precise
prediction of epidemic.
4.2 To prioritize areas according to
epidemic risk and prescribe line of epidemiological operation of each
individual locality.
4.3 To develop Special Response Team
(SRT) and Operation Plan in order to response timely when epidemic occurs or in
epidemic prone situation.
5. Development of appropriate malaria
control strategies to cover dynamic malaria situation:
5.1 To up-grade potential and
capacity of health personnel’s at different levels, both public and community to control malaria according to local condition.
5.2 To promote collaboration of malaria control among public and
community
organizations
in order to enhance Community Empowerment.
5.3 To conduct research on drug and measure preventing distribution
of drug resistance.
5.4 To develop Disease Prevention
Technology concerning pattern of
mosquito-net utilization among
risk group and vector control.
6. To promote collaboration among sectors, institutes and organization including
government, private sectors, community organizations, international
organizations and neighboring countries; and promote Thailand as Training
Center for personnel development and Center for Malaria Research in South East
Asia Region.
7. To promote expansion of Integration
area.
4. Organization
structure.
Previous
organization structure of the Malaria Control Programme
The Malaria Control Programme was a
Division of the Department of Communicable Disease Control (CDC) of the
Ministry of Public Health (MOPH). The Director-General, CDC, was responsible
for the direction and implementation of the control programme, staff,
equipment, and budget. Malaria
Division was responsible for malaria control policy development, planning &
evaluation, budget allocation, training, monitoring and supervision. At the country level the programme
comprised of five Malaria Regions, each being directed by a Medical Officer,
Regional Director, who was directly responsible to the Director-General,
CDC. There were 33 Malaria Zone
Offices(provincial level) and 302 Malaria Sector Offices (district level) each
being responsible for the malaria control operation. The Malaria Control Programme remains organizationally
vertical, although some activities such as case detection have been partially
integrated into the general health service, especially in low malarious
areas. Vector control activities,
active and passive case finding by
means of specialized malaria clinic remained under the responsibility of the
Malaria Control Programme structure.
Reorganization of Malaria Control
Programme Fiscal Year 1997
(Commenced October 1996)
Due
to the financial constraints and the government policy on downsizing of the
government institutes together with the continuous downward trend of malaria
during the last decade, the Department of CDC reorganized the Malaria Control Programme structure by
merging the MCP with the Filariasis and Dengue Haemorrhagic Fever Control
Programmes. The new structure has
been in effect since October 1996.
Control of filariasis is a vertical programme, similar to the MCP
whereas DHF Control is totally integrated into the general health
services. The policy for the
restructuring was to make best utilization of human resources, budget and
equipment for control of all mosquito-borne diseases, and to minimize
relatively high cost of the MCP.
At the central level there remained
three technical divisions; Malaria Division, Filariasis Division and DHF
Section under the General Communicable Disease Control Division. At the country level the programme
comprises five regions, each directed by a Medical Officer, Director of Office
of Vector-borne Disease Control (VBDO), who is directly responsible to the
Director-General, Department of CDC.
There are 39 Vector-borne Disease Control Centers(VBDC) and 302
Vector-borne Disease Control Units (VBDU) at provincial and district levels,
respectively.
5. Malaria epidemiology.
Malaria is forest-related with the
disease being prevalent along the international borders whereas in central
plain areas, malaria transmission has been eliminated for more than two
decades. Malaria transmission in
the forested areas is intense, due to the presence of highly efficient vectors,
enhanced vector longevity, and intensive population movement.
An. dirus and An. minimus are principle
vectors. An. dirus is the
most important vector within the forest setting while An. minimus, plays
a major role due to its wide distribution in the forest-fringe areas.
The parasites commonly found are P.
falciparum (51%) and P. vivax(48%), P. malariae accounts for less than 1%. P. ovale is very rare. Proportion of P. falciparum is
observed to be very much related with therapeutic efficacy of national treatment guidelines and
some certain epidemics that affected
major transmission foci
Current malaria situation
The epidemiological data showed a
downward trend in total cases from some 200,000 cases in 1991 to some 100,000
cases in 1996. In addition to Thai
cases, foreigner cases (mostly Burmese) have been on the increase, from 48,000
cases in 1991 to 66,000 cases in 1997.
During
1997-1999, due to epidemics of P. falciparum in some provinces in the
South and P. vivax along the Thai-Cambodian border, total Thai cases
reported increased to 128,833. The
annual parasite incidence (API) was 2.27 per 1000 population in 1999. Foreigner cases continued to increase
to some 79,490. Burmese accounts
for 90% of foreigner cases,
mostly P.
falciparum (more than
80%).
There
were several causes of epidemics, one related to the financial crisis that
coincided with the occurrence of epidemics, to be discussed later in this
paper. It is anticipated that
malaria epidemics will continue and the Control Programme may take a few years
to overcome the problem in order to bring down the country malaria incidence to an acceptable
level.
However,
in spite of increasing morbidity, the mortality continues to decrease greatly
to a level of 1.0 death per 100,000 population in 1998, total deaths of 608
Therapeutic
efficacy study was conducted in
1997 at 6 drug resistance monitoring sites. Results showed that the current treatment regimens using
either mefloquine alone or mefloquine in combination with artemisinin
derivatives remained effective
Malaria epidemics in 1997-1999
It is noted that there was an
increasing trend of total malaria cases during fiscal year 1997-1999. Malaria epidemics were observed in
various parts of the country, for
instance:
Sakaew
Province, along the Thai-Cambodian border, reported 613 malaria cases in 1995,
some 900 in 1996 and 4800 cases in 1997.
In 1998 total reported cases were 4,189 to be noted that P.
falciparum accounted for 16% whereas it had been over 60% prior to the
outbreak, P. vivax becoming the dominant species Changing of parasite formula was
considered probably due to the impact of artemisinin derivatives that were
launched in 1995.
Chanthaburi
and Trat Provinces, the long known areas for multi-drug resistant foci, malaria
cases doubled in 1998 compared with 1996-1997. Increasing proportion of P. vivax was observed.
The
southern peninsula, 8725 cases were reported in 1996 whereas 13,623 and 47,149
were reported in 1997 and 1998 respectively. Proportion of P. falciparum increased from 45% in
1996 to 56% during epidemics in 1998.
There was re-emergence of malaria transmission in many districts where
malaria transmission had ceased.
Phuket Province, where malaria transmission has been eradicated for
years reported 7 confirmed indigenous cases reported in 1998.
All cases contracted the infections in hilly forested areas where
migrant laborers were employed.
Fortunately, the transmission took place outside tourism areas.
There
are multi-factorial causes for epidemics during 1997-1998; some possible
causes are shown below:
·
malaria
transmission has ceased for years in most of the areas, in particular the
southern peninsula until the Programme withdrew vector control (mainly IRS
using DDT) but area receptivity to malaria is still very high.
·
inactive
surveillance due to the same reason
·
there
was shifting of long-action DDT to relative short-action synthetic pyrethroids.
·
reduced
manpower and operational budget for the Malaria Control Programme (to be
discussed later)
·
sharing
of human resources and budget with other vector-borne disease control, e.g. DHF
control which is on the increase (to be discussed later)
Fortunately,
the main malaria transmission foci with multi-drug resistant P. falciparum along
the Thai-Myanmar border remained more or less stable.
6. Stratification of
Malarious Areas.
The Thai Malaria Control Programme
stratifies the country into 4 categories :
(1) Control area with transmission (referred to as A) This category is divided
into two
-
Perennial transmission area, where transmission is reported throughout the year
or at least 6 months per year, is designated as A1
- Periodic transmission area, where
transmission is reported 5 months or less per year, is disignated as A2
(2) Control area without
transmission (referred to as B)This category is divided into two
subcategorized, namely B1
and B2.
- High risk are (B1), transmission was not reported within the last 3
years but primary of secondary
vectors are found. Consequently,
the area is potentially suitable for malaria transmission (high and
moderate receptivity).
- Low risk areas (B2), transmission was not reported within
the last 3 years and
both primary and secondary vectors are not found. Suspected
vector, however, may be found (low and non receptivity).
(3)
Pre-integration area is
district-wide area that has been categorized as low risk for at least 3 years and local health services,
such as hospitals and health centers, are able to perform case detection,
treatment and case investigation.
(4) Integration area is province-wide area that has
been pre-integration area for at
least 3 years and Provincial Health Office is capable of managing all activities concerning malaria.
Population covered under different stratified areas are shown as below
Table 1 Number
of Population under different malaria stratified areas, 1998.
|
Area stratification |
Population covered |
% covered |
|
1 Control area 1.1 Control
area with transmission ·
perennial
transmission (A1 area) ·
periodic
transmission (A2 area) |
3,396,000 729,719 2,666,000 |
6.00 1.29 4.71 |
|
1.2
Control area without
transmission ·
high
risk area in presence of primary and/or secondary vectors (B1 area) ·
low
risk area, no known vectors, suspected vectors may be found (B2 area) |
38,013,000 9,761,000 28,252,000 |
67.18 17.25 49.93 |
|
2
Pre-integration area (PA) |
2,936,000 |
5.19 |
|
3 Integration
area (IA) |
12,237,000 |
21.63 |
|
Total population |
56,582,000 |
100 |
7. Malaria situation in border areas
7.1
Malaria
cases in border area (FY 1996-1998)
|
|
1996
|
1997 |
1998 |
|||
|
Border
area |
Thai |
Foreign
|
Thai |
Foreign National |
Thai |
Foreign National |
|
Thai-Myanmar (10 provinces) |
60,365 |
58,841 |
58,439 |
59,699 |
56,829 |
56,939 |
|
Thai-Laos (10 provinces) |
3,616 |
1,648 |
3,618 |
2,472 |
2,812 |
1,592 |
|
Thai-Cambodia (6 provinces) |
8,699 |
294 |
20,571 |
3,718 |
16,350 |
8,015 |
|
Thai-Malaysia (4 provinces) |
2,523 |
44 |
3,367 |
107 |
10,740 |
24 |
|
Total |
75,203 |
60,827 |
85,995 |
65,996 |
86,731 |
66,570 |
7.2
Malaria
cases in 10 provinces along Thai-Myanmar border (FY 1996-1998)
|
|
1996
|
1997 |
1998 |
|||
|
Border
area |
Thai |
Foreign
|
Thai |
Foreign National |
Thai |
Foreign National |
|
1.
Tak |
22,432 |
45,336 |
25,751 |
43,014 |
24,925 |
38,740 |
|
2.
Kanchanaburi |
11,607 |
3,524 |
7,249 |
3,981 |
7,996 |
5,037 |
|
3.
Mae
Hong Son |
8,879 |
2,134 |
7,639 |
3,901 |
5,186 |
2,801 |
|
4.
Prachuap
Kiri Khan |
3,235 |
95 |
3,651 |
350 |
4,570 |
834 |
|
5.
Chiang
Mai |
4,118 |
701 |
5,141 |
1,872 |
3,682 |
2,010 |
|
6.
Ratchaburi |
3,143 |
462 |
3,044 |
1,527 |
3,623 |
2,360 |
|
7.
Chumporn |
1,737 |
143 |
2,120 |
232 |
2,528 |
164 |
|
8.
Ranong |
1,526 |
4,053 |
1,678 |
2,455 |
2,467 |
2,996 |
|
9.
Phetchaburi |
1,646 |
0 |
1,375 |
24 |
951 |
0 |
|
10.
Chiangrai |
2,042 |
2,393 |
791 |
2,343 |
901 |
1,997 |
|
Total |
60,365 |
58,841 |
58,439 |
59,699 |
56,829 |
56,939 |
There are multi-factorail causes for
epidemics during 1997-1998; some possible causes are shown below:
·
Malaria
transmission has ceased for years in most of the areas. In particular the
southern peninsula until the Programme withdraw vector control (mainly IRS
using DDT) but area receptivity to malaria is still very high.
·
Inactive
surveillance due to the same reason.
·
There
was shifting of long-action synthetic pyrethroids.
·
Reduced
manpower and operational budget for the Malaria Control Programme.
·
Sharing
of human resources and budget with other vector-borne disease control, e.g. DHF
control which is on the increase.
Fortunately, the main malaria transmission foci with
multi-drug resistant P.falciparum
along the Thai-Myanmar border remained more or less stable.
8. Vector Control
Background
Insecticide
residual spraying (IRS) using DDT was introduced into the Malaria Control
Programme (MCP) in 1949. Its
impact on mosquito vectors and malaria was obvious. This measure was gradually expanded to cover all malaria
transmission areas. During
1970s-1980s IRS remained single main vector control measure for the MCP. Its dosage was 2 gm/sq. m. and it was
applied 2 cycles per year in mountainous and high malarious areas, 1 cycle in
the late attack phase.
In
1975 following increase of malaria in various areas, including resurgence of
malaria in eradication areas, regular focal spray was introduced to cope with
epidemics. In 1976 DDT emulsion
was introduced in order to improve
community compliance. Other
alternative methods were tested or introduced into the MCP. Abate 50% EC, biological control using
larvivorous fishes, mosquito repellents were also introduced.
In
1979 during massive malaria outbreaks along the Thai-Cambodian border space
spraying (fogging) using Malathion was introduced to control explosive
epidemics in refugee camps.
Various
kinds of indigenous larvivorous fishes were tested; panchax, guppy and gambusia
against different anopheles larvae.
Various insecticides were tested against DDT; Bendiocarb(0.4 gm/sq.m 2
cycles/yr.) in 1980. DDT emulsion
against DDT wetable powder, etc.
It
was reported that Anopheles minimus developed a shift in its behavior
from being highly endophilic to exophilic.
During
1982-1987 Fenitrothion was donated by the Government of Japan (JICA) and used
in the Thai-Cambodian areas.
In
1988 the MCP gradually changed its philosophy from mainly relying on IRS (using
mainly DDT) and adopted other vector control measures; i.e. integrated vector
control. Personal protection using
plain mosquito nets and mosquito repellents were recommended for use by the
general population. The MCP initiated the so-called “Malaria Self Reliance
Village” project in high malarious areas.
Seed money for village fund were kindly sponsored by WHO. The objectives were to increase
mosquito net coverage and its utilization. One of the Malaria Regional Offices trained hill tribe
housewives to produce home-made net to expand net coverage.
A
pilot study on IRS using synthetic pyrethroids (Deltamethrin and
Lambdacyhalothrin) was conducted in 1995.
In
1995 the MCP decided to change the insecticide policy. DDT has been banned by the government
since 1995 due to some political reasons.
The last purchase was made in 1995. However there is still considerable amount of DDT leftover
and is still being utilized in remote mountainous areas. Deltamethrin and lambdacyhalothrin were
only two alternative pyrethroids available at the time and were comparatively
tested against DDT in a large scale field trial. The results were reviewed and discussed by a group of
experts. Following assessment in
entomological, epidemiological, social and cost-effectiveness analysis the
group recommended DDT be replaced by Deltamethrin. Since DDT has longer effect and currently being applied once
a years whereas Deltamethrin has to be applied twice a year. The operational cost for IRS doubles
that of DDT. The cost of
Deltamethrin alone is 2 times higher than that of DDT.
Current Vector Control
At
present the vector control does not rely mainly on IRS as in the old days. Alternative vector control such as
fogging, impregnated mosquito net, mosquito repellent and bio-environmental
control are supplementary measures to IRS. In addition other compounds are being tested and compared
with Deltamethrin.
In principle vector control is being carried out in all active transmission areas (i.e. A1 A2 areas in Table 1). It is also applied in B1 areas where resurgence of malaria has been confirmed and in some circumstances such as massive movement of refugees or non-immune labours.
The
criteria for application of each vector control activity are as follows:
Indoor residual spraying (IRS)
Deltamethrin 5% WP is operationally
employed by the MCP. The dosage is
20 mg./sq. m. IRS is conducted
twice a year in perennial transmission area ( A1 areas) and once a year in
periodic transmission area (A2 area) covering the transmission season.
DDT
75% wdp. is employed only in remote and difficult areas at the dosage of 2
gm./sq.m once a year. Its use has
been phased out since 1996. It is expected that the MCP will use up the
leftover stockpile by 1999.
Other chemicals such as Etofenprox,
Alphacypermethrin, Bifenthrin, etc. are being tested.
Impregnated mosquito nets (IMN)
This activity has been introduced
recently to supplement IRS. In
areas where public acceptance to IRS is low and net coverage is higher than 60-70%
IMN will replace IRS. The MCP
staff treat villagers owned nets.
In high malaria transmission areas free of charge nets offered by the
MCP are distributed to the poor who can not afford to purchase nets.
Nets
are treated by dipping with Permethrin 0.3 gm./sq.m, twice a year. Other chemicals are now being tested
and compared with Permethrin, e.g. Alphacypermethrin, Deltamethrin (SC)
Thermal fogging
Thermal fogging has a relatively
limited role. It is applied during
malaria outbreaks and or in uncontrolled transmission areas. In principle it is applied once a week
for 4 consecutive weeks. Chemicals
used were Malathion in the old days and Deltacide®
(Esbioallethrin +
Deltamethrin + Piperonyl Butaoxide)at present.
Chemical larviciding
Abate
was used to control malaria vectors in urban areas but now it is abandoned.
Bio-environmental control
Environmental
control was introduced for years through the primary heath care approach
without satisfactory success. At
present biological control using larvivorous fishes is now being encouraged by
the MCP. At any MCP field office
larvivorous fishes (mostly guppy) are distributed to villagers. Malaria volunteers also involve in
rearing larvivorous fishes in artificial and natural breeding places. Fishes are now being promoted for DHF
control. Other biological control,
such as bacteria was tested in field circumstances but never reach operational
stage.
Vector Control Activities
Vector control activities during
1994-1998 are shown in Table 2
Table 2 Vector Control for Malaria in
Thailand, 1994-1998
|
Method |
1994 |
1995 |
1996 |
1997 |
1998 |
|
Indoor Residual Spraying (IRS) 1 Pop.
protected under planned
spray operation (000) 2 Pop.
protected under
emergency (due to epidemics)
spray operation (000) |
2,046 0.004 |
1,440 0.005 |
1,316 0.005 |
1,038.905 5.136 |
930.531 58.577 |
|
Biological
control Pop. protected (000) |
2.271 |
6.269 |
2.337 |
3.209 |
3.010 |
|
Source reduction Pop. protected (000) |
0.052 |
0.054 |
0.03 |
0.051 |
0.042 |
|
Personal protection Pop. protected (000) |
0.524 |
0.84 |
1.153 |
1.378 |
1.521 |
9. Surveillance & case detection method
Passive case detection (PCD) is proved to be more cost-effective
than active case detection.
Malaria clinic system has been one of the most cost-effective case
detection method for malaria control. Its impact on reduction of mortality due
to malaria is obvious. House to house visiting has been withdrawn and replaced
by the so called “Special Case Detection” (SCD) which is active
case finding carried out during peak transmission or epidemics to supplement
inaccessible PCD.
Mobile malaria clinic is another
activity similar to SCD but with microscopic facilities. It is more costly than traditional
PCD. Periodic mobile clinic
or Fixed schedule mobile clinic (on a fixed weekly schedule) was
observed to have low institutional costs per smear, but relatively high cost
per positive case. For patients,
Periodic mobile clinic had low community costs (those paid by patients and
their families).
In
some circumstances, a combination of central, peripheral malaria clinics and
periodic clinics was proved to be cost-effective, maximize access to malaria
treatment (thus prevent malaria deaths) and minimize the community costs. (Ettling
et al, 1991)
10. Identification of risk factors for
malaria and area stratification
High Annual Blood Examination Rate
(ABER) is no longer indicating
high coverage of surveillance.
Low slide positivity rates (SPR) does not always reflect low malaria situation. In another word it may indicate the
un-targeted surveillance. If
malaria risk is accurately identified by age, sex, occupation and spatial data,
blood examination can be more directed towards target groups and more
cost-effective. This stratification
also requires regular assessment of local malaria epidemiology which is
dynamic.
11. Method of blood examination
At present there are non-microscopic
examination based on Antigen-capture assay (dipstick technology) recently
developed and made available for commercial use. Therefore, in circumstances where malaria diagnosis and
treatment is integrated into the general health services to minimize
institutional cost for malaria control, or when skilled microscopists are
scarce, the use of dipstick technology is potential as it is more
cost-effective than the microscope- based system.
A preliminary study conducted in
Thailand indicated that Institutional cost of dipstick was 60 Baht per one
positive compared with 250 Baht for microscopic examination. Community cost was not fully calculated
in the study but it is assumed that cost incurred by patients in the dipstick
group is much less than those in the microscopic group because time spending at
the clinics is much shorter. (Plasai, 1996, unpublished data)
The
dipstick has not been introduced extensively in the Control Programme since its
unit cost remains high and the Programme offers free service.
12. Case treatment
1 Treatment of uncomplicated P.falciparum
cases
All
microscopically confirmed P.falciparum cases are treated according to
level of mefloquine resistance of areas.
The Malaria Control Programme stratifies the total areas of the country
based upon drug sensitivity monitoring data, i.e. in-vivo tests of
mefloquine 750 mg. standard treatment and follow-up for 28 days.
|
Cure rates
(%) |
Level of mefloquine resistance |
Area |
|
|
|
|
|
70+ |
non or low |
the rest of the areas, plain areas and central parts |
|
50-70
(+RIII cases) |
moderate |
Sakaew Province, at the Thai-Cambodian border |
|
less than 50% (+ many R III cases)
|
high |
Tak Province, at the Thai-Myanmar border Trat and Chanthaburi Provinces, at the Thai-Cambodian
border |
Non or low mefloquine resistant
areas:
First line drug Mefloquine
750 mg. and primaquine 30 mg. single dose
Second line drug Quinine + tetracycline
for 7 days or quinine alone for 7 days and
primaquine
30 mg. on the last day.
Third line drug Artesunate or artemether 700 mg. in divided dose
over 5 days
and primaquine
30 mg. on the last day.
Moderate mefloquine resistant areas:
First line drug Mefloquine
750 mg. followed by artesunate or artemether at 6-hour interval 300 mg. on Day
1
Artesunate
or artemether 300 mg. and primaquine 30 mg. on Day
2
Second line drug same as non-low
mefloquine resistant
Third line drug same
as non-low mefloquine resistant
High mefloquine resistant areas:
First line drug Mefloquine 750 mg. start followed by
artesunate or artemether 300 mg. on Day 1
Mefloquine 500 mg. at 6 hour
interval
Day 2
artesunate or artemether 300 mg. and primaquine 30 mg.
Second line drug same as non-low
mefloquine resistant
Third line drug same as non-low mefloquine resistant
2 Treatment of P.vivax and
P.ovale cases
Chloroquine 1500 mg. base over 3 days
Primaquine
15 mg. daily for 14 days
3 Treatment of P.malariae cases
Same as P.vivax but no
primaquine
4 Mixed infections, if with P.falciparum malaria, treat as P.falciparum
malaria
Presumptive treatment
As
mentioned earlier that presumptive treatment using sulfadoxine/ pyrimethamine
(1000/50 mg.) together with 30 mg. primaquine, is given to symptomatic cases with suspected
history to suppress symptoms and interrupt transmission. Presumptive treatment is given by
health centers and malaria volunteers.
Realizing that presumptive treatment is underdose treatment and may
induce drug resistance, the
Control Programme decided to phase out presumptive treatment by the end of
2001. Early diagnosis and prompt
radical treatment according to parasite species is promoted to replace
presumptive treatment.
Chemoprophylaxis
Chemoprophylaxis
is not recommended for general population. Personal protection using mosquito repellents and
impregnated bed nets is strongly recommended. In case that chemoprophylaxis is unavoidable, daily
doxycycline(100 mg.) for no longer than 3-4 weeks is recommended for all
instances.
Standby
drug for special groups such as military staff, laborers crossing border, etc.,
is to be considered by the Malaria Regional Directors. Drug of choice is artemisinin
derivatives 700 mg. over 5 days for adults and children over 4 years old. Younger children and pregnant women are
prescribed with quinine for 7 days.
13. National Anti-malarial Drug policy
Drug
policy can be developed to minimize cost as follows:
Presumptive
treatment using sulfadoxine/pyrimethamine
is now abandoned in order to minimize its impact on drug resistance as
well as reduce cost incurred by the Control Programme.
Regular
monitoring of drug resistance enable the Control Programme to change treatment
guideline whenever essential. At
present, although in-vitro microtest plates are purchased from abroad at
high cost and cost for conducting therapeutic efficacy study is high, the
Control Programme decided to carry on this activities. Cost incurred to the Control Programme
and community when drug resistance emerges is much higher than the cost of the
monitoring system.
Improved
management of drug stockpile is required to ensure quality assurance of drugs,
ensure continuous supply and avoid waste (expired drugs).
Efficient management of stocks should be applied for all supplies for
the Control Programme.
14. Health education and community empowerment
for malaria control
The
country has been investing enormously both financial and human resources on
health education schemes, production of health education and the so called
“malaria self-reliance villages”.
Following the reorganization, the health education materials were
produced in package for all mosquito-borne diseases to minimize
cost.
Active
community participation for
malaria control and prevention can be strengthened by modern techniques, such
as participatory rural appraisal (PRA) but the capital investment for
this is high and need long term capability strengthening of field staff.
15. Research and training
During the financial crisis, budget
of conducting operational research and staff capability strengthening were the
first budget lines to be reduced.
We anticipated that no impact would be observed if this is
transient. However, prioritization
is helpful to allocate budget to the essential research topics and training
courses. External funding should
be also explored.